Pharmaceutical Sciences

Research Agricultural

Total number of Record(s): 108
शीर्षक मुख्य जाँचकर्ता शुरुवाती साल निधीयन एजेंसी ध्यानाकर्षण क्षेत्र
Pharmacological and Molecular Approaches to Investigate Selected Drug in Model of Ischemia-Reperfusion Injury in Streptozotocin Induced Diabetic Rats Prof Dharamvir Singh Arya, All India Institute of Medical Sciences (AIIMS), New Delhi 2018 Bristol-Myers Squibb (BMS) Company, USA Pharmacology
Centre of Excellence for Epilepsy - Phase - II Dr. Manjari Tripathi, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi, Dr. Tapan Kumar Gandhi, Associate Professor, Indian Institute of Technology (IIT), Delhi, Dr. Pravat Mandal, Professor, National Brain Research Centre (NBRC), Gurugram 2018 Department of Biotechnology (DBT), Government of Inida NA
Virtual National Oral Cancer Institute (VNOCI) Dr. Kodaganur S Gopinath, Surgical Oncologist, Bengaluru Institute Of Oncology, Prof. Saumyadipta Pyne, Scientific Director, Indian Institute of Public Health (IIPH), Hyderabad, Dr. Annapoorni Rangarajan, Assistant Professor, Indian Institute of Science (IISc), Bengaluru, Dr. Ramaswamy Subramanian, Professor, Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Prof. Tapas K Kundu,Professor, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru, Dr. Birendranath Banerjee, Associate Professor, Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar, Dr. Rekha V Kumar, Professor, Kidwai Memorial Institute of Oncology (KMIO), Bengaluru, Prof. Partha Pratim Majumder, Professor, National Institute of Biomedical Genomics (NIBG), Kalyani Dr. Anupam Chatterjee, Professor, North-Eastern Hill University (NEHU), Shillong, Dr. Tessy Thomas Maliekal, Scientist, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram 2018 Department of Biotechnology (DBT), Government of Inida NA
Development of PD-1/PDL-1 check point inhibitor(s) for adjuvant therapy Dr. C Gopi Mohan, Associate Professor, Amrita Vishwa Vidyapeetham Amritapuri Campus (AVVAC), Kollam 2018 Department of Biotechnology (DBT), Government of India, New Delhi Adjuvant therapy
Manufacturing Solutions for the Preparation of Siddha Medicines (Traditional Medicines Originated from Tamilnadu) Dr. S Senthilvelan, Department of Mechanical Engineering, Indian Institute of Technology (IIT), Guwahati, Assam 2017 Impacting Research, Innovation and Technology (IMPRINT), Ministry of Human Resource Development (MHRD), Govt. of India Siddha Medicines
Dementia Science Programme: Incidence/ Prevalence/ Risk/ Intervention analysis of dementia and basic research thereof Dr. Shiv Sharma, Professor, National Brain Research Centre (NBRC), Gurugram, Dr. N K Arora, Professor, The INCLEN Trust International, New Delhi 2017 Department of Biotechnology (DBT), Government of Inida NA
Synthesis, characterization and pharmacokinetic evaluation of potent integrin antagonists for the prevention and treatment of fungal infections Dr. Diksha Katiyar, Associate Professor, Department of Chemistry, Banaras Hindu University (BHU), Varanasi, Uttar Pradesh 2017 Science and Engineering Research Board (SERB), Department of Science & Technology (DST), Government of India NA
Novel potential antifungal drugs active against multidrug-resistant yeasts from the Candida genus Dr. Rajendra Prasad, Professor, Amity University (AU), Noida, Uttar Prasdesh 2017 Government of Poland Antifungal drugs
DOS approach for sesquiterpene anti-malaria drugs Dr. Laxmidhar Rout, Assistant Professor, Department of Chemistry, Berhampur University, Berhampore, West Bengal 2017 Science and Engineering Research Board (SERB), Department of Science & Technology (DST), Government of India NA
Pharmacological mimicking of cold via cold thermo- receptors (Transient Receptor Potential Ankyrin (A) 1 and Metastatin (M) 8) and energy regulation: Novel implications in obesity and type-2 diabetes Dr. Mahendra Bishnoi, Scientist, National Agri Food Biotechnology Institute (NABI), Sahibzada Ajit Singh Nagar, Punjab 2017 Government of Poland Obesity and type-2 diabetes